Cutler Group LP Jazz Pharmaceuticals PLC Call Options Transaction History

Cutler Group LP

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2021 Oct 26, 2021	SELL	$128.64 - $184.79 $25,727 - $36,958	-200 Reduced 15.38%	1,100 $78,000
Q2 2021 Jul 19, 2021	BUY	$160.2 - $186.42 $208,259 - $242,345	1,300 New	1,300 $89,000
Q4 2018 Feb 05, 2019	SELL	$115.94 - $166.74 $173,910 - $250,110	-1,500 Closed	0 $0
Q3 2018 Nov 07, 2018	BUY	$161.01 - $180.57 $241,515 - $270,855	1,500 New	1,500 $1,000
Q1 2018 May 11, 2018	SELL	$135.59 - $157.16 $203,385 - $235,740	-1,500 Closed	0 $0
Q4 2017 Jan 17, 2018	SELL	$131.06 - $150.39 $26,212 - $30,077	-200 Reduced 11.76%	1,500 $1,000
Q3 2017 Oct 17, 2017	BUY	$142.62 - $155.6 $242,454 - $264,520	1,700	1,700 $20,000

512

57.5M

188K

133K

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $7.71B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.